Paper199342
Erythrophagocytosis by epithelial cells of a breast carcinoma.
Marin-Padilla M. Cancer, 1977. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Erythrophagocytosis by epithelial cells of a breast carcinoma. Papers, record 199342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/199342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma, Intraductal, Noninfiltrating | Major topic |
| Erythrocytes | Major topic |
| Phagocytosis | Major topic |
| Adult | |
| Epithelial Cells | |
| Female | |
| Hemorrhage | |
| Humans | |
| Neoplasm Metastasis |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37371090 | Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis. | Cells | 2023 | https://conductscience.org/library/papers/37371090 | PubMed |
| 34259988 | Phagocytic rhabdomyosarcoma cells in bone marrow. | Int J Hematol | 2021 | https://conductscience.org/library/papers/34259988 | PubMed |
| 32219096 | Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer. | Front Nutr | 2020 | https://conductscience.org/library/papers/32219096 | PubMed |
| 23888112 | Nano-hole induction by nanodiamond and nanoplatinum liquid, DPV576, reverses multidrug resistance in human myeloid leukemia (HL60/AR). | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23888112 | PubMed |
| 23237552 | On the origin of cancer metastasis. | Crit Rev Oncog | 2013 | https://conductscience.org/library/papers/23237552 | PubMed |
| 20839033 | Perspectives on the mesenchymal origin of metastatic cancer. | Cancer Metastasis Rev | 2010 | https://conductscience.org/library/papers/20839033 | PubMed |
| 20181022 | Cancer as a metabolic disease. | Nutr Metab (Lond) | 2010 | https://conductscience.org/library/papers/20181022 | PubMed |
| 19893578 | The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. | EMBO Rep | 2009 | https://conductscience.org/library/papers/19893578 | PubMed |
| 6654047 | Cell necrosis and endocytosis (apoptosis) in an embryonal rhabdomyosarcoma of the orbit. | Graefes Arch Clin Exp Ophthalmol | 1983 | https://conductscience.org/library/papers/6654047 | PubMed |
| 3907822 | Mechanisms of tumor invasion: evidence from in vivo observations. | Cancer Metastasis Rev | 1985 | https://conductscience.org/library/papers/3907822 | PubMed |
| 1996360 | Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1996360 | PubMed |
| 209609 | Spheroidal filamentous inclusion body cells in von Recklinghausen's disease. | Virchows Arch A Pathol Anat Histol | 1978 | https://conductscience.org/library/papers/209609 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/199342
GET https://conductscience.org/api/papers/v1/199342/authors